Securities,
Civil Litigation,
Law Practice,
Corporate
Jun. 14, 2018
Judge says he’ll award $52.5 million in attorney fees in shareholder suit
A federal judge has said he plans to approve $52.5 million in attorney fees, part of a record $250 million settlement in an unusual insider trading class action related to an attempted hostile takeover of Allergan in 2014 by Valeant Pharmaceuticals International Inc., and Pershing Square Capital Management.
SANTA ANA -- A federal judge has said he plans to approve $52.5 million in attorney fees, part of a record $250 million settlement in an unusual insider trading class action related to an attempted hostile takeover of Allergan in 2014 by Valeant Pharmaceuticals International Inc. and Pershing Square Capital Management.
U.S. District Judge David O. Carter told attorneys from Bernstein Litowitz Berger & Grossmann LLP and Kessler T...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
